Clemensson L: Difference between revisions
From Bioblast
Beno Marija (talk | contribs) No edit summary |
Beno Marija (talk | contribs) m (Beno Marija moved page Clemensson Laura to Clemensson L) |
(No difference)
|
Revision as of 11:12, 27 August 2018
Name | Clemensson Laura, |
---|---|
Institution | University of Uppsala, Department of Neuroscience
Functional Pharmacology |
Address | BMC, Box 593,, 751 24 |
City | Uppsala |
State/Province | |
Country | Sweden |
[email protected] | |
Weblink | |
O2k-Network Lab |
Labels:
Publications
Published | Reference | |
---|---|---|
Liepinsh 2024 Br J Pharmacol | 2024 | Liepinsh E, Zvejniece L, Clemensson L, Ozola M, Vavers E, Cirule H, Korzh S, Skuja S, Groma V, Briviba M, Grinberga S, Liu W, Olszewski P, Gentreau M, Fredriksson R, Dambrova M, SchiΓΆth HB (2024) Hydroxymethylglutaryl-CoA reductase activity is essential for mitochondrial Ξ²-oxidation of fatty acids to prevent lethal accumulation of long-chain acylcarnitines in the mouse liver. Br J Pharmacol [Epub ahead of print]. https://doi.org/10.1111/bph.16363 |
Abstracts
Published | Reference | |
---|---|---|
Clemensson 2018 MiP2018 | 2018 | No abstract. |